Published in Clin Infect Dis on October 12, 2011
Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis (2013) 2.22
Recent trends in the serologic diagnosis of syphilis. Clin Vaccine Immunol (2014) 1.02
Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS One (2013) 0.97
Response to therapy following retreatment of serofast early syphilis patients with benzathine penicillin. Clin Infect Dis (2012) 0.91
Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect Dis (2013) 0.87
A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy. BMC Infect Dis (2015) 0.87
Emerging trends and persistent challenges in the management of adult syphilis. BMC Infect Dis (2015) 0.82
Predictors of serological cure after treatment of early syphilis. Clin Infect Dis (2012) 0.78
Rapid Treponema pallidum clearance from blood and ulcer samples following single dose benzathine penicillin treatment of early syphilis. PLoS Negl Trop Dis (2015) 0.78
Potential Predictors for Serofast State after Treatment among HIV-Negative Persons with Syphilis in China: A Systematic Review and Meta-Analysis. Iran J Public Health (2015) 0.77
Could lengthening minocycline therapy better treat early syphilis? Medicine (Baltimore) (2016) 0.75
Jarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy. J Int AIDS Soc (2014) 0.75
Rate of Decline in Nontreponemal Antibody Titers and Seroreversion After Treatment of Early Syphilis. Sex Transm Dis (2017) 0.75
Factors associated with syphilis treatment failure and reinfection: a longitudinal cohort study in Shenzhen, China. BMC Infect Dis (2017) 0.75
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med (2005) 5.05
Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev (1999) 4.63
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med (1997) 4.11
Serologic response to treatment of infectious syphilis. Ann Intern Med (1991) 2.38
A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis (2002) 2.29
Serological response to syphilis treatment. A new analysis of old data. JAMA (1985) 2.23
Treatment for early syphilis and reactivity of serologic tests. JAMA (1972) 2.07
Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis (2009) 1.94
A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis (2010) 1.64
Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis (2009) 1.54
Age-associated changes within CD4+ T cells. Immunol Lett (2006) 1.38
Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis (2006) 1.15
Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California. Sex Transm Dis (2010) 1.07
VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages. J Infect Dis (1993) 1.07
Jarisch-Herxheimer reaction in early syphilis treated with crystalline penicillin G. J Am Med Assoc (1948) 1.03
Adverse reactions in syphilis therapy. J Am Vener Dis Assoc (1976) 0.96
[Clinical analysis and study of immunological function in syphilis patients with seroresistance]. Zhonghua Yi Xue Za Zhi (2009) 0.93
Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med (2008) 0.91
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 9.73
Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. JAMA (2004) 4.28
Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med (2002) 3.86
Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med (2004) 2.95
Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis (2005) 2.70
Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis (2004) 2.67
A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis (2009) 2.64
Dose-related effects of smallpox vaccine. N Engl J Med (2002) 2.55
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55
Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ (2006) 2.43
A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr (2004) 2.42
Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis (2005) 2.40
Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis (2013) 2.33
Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis (2005) 2.33
Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis (2006) 2.31
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30
A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis (2002) 2.29
Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol (2003) 2.24
The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect (2011) 2.19
The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction. J Acquir Immune Defic Syndr (2015) 2.19
Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis (2005) 2.18
Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS One (2008) 2.09
The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med (2011) 2.06
Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06
Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care. Clin Infect Dis (2013) 2.06
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Nonfluoride caries-preventive agents: executive summary of evidence-based clinical recommendations. J Am Dent Assoc (2011) 2.05
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (2010) 1.99
Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol (2009) 1.96
Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94
Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis (2009) 1.94
Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J (2009) 1.91
Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol (2006) 1.89
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis (2008) 1.87
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis (2012) 1.87
Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol (2002) 1.85
General practitioners with a special clinical interest: a model for improving respiratory disease management. Br J Gen Pract (2002) 1.80
Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2013) 1.77
Measuring sex partner concurrency: it's what's missing that counts. Sex Transm Dis (2007) 1.73
Telling children they have HIV: lessons learned from findings of a qualitative study in sub-Saharan Africa. AIDS Patient Care STDS (2010) 1.71
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun (2004) 1.69
Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States. Sex Transm Dis (2009) 1.68
Sexual risk behaviors associated with having older sex partners: a study of black adolescent females. Sex Transm Dis (2002) 1.65
A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis (2010) 1.64
The cost effectiveness of gonorrhea screening in urban emergency departments. Sex Transm Dis (2005) 1.64
HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples. J Acquir Immune Defic Syndr (2013) 1.64
Bed net ownership, use and perceptions among women seeking antenatal care in Kinshasa, Democratic Republic of the Congo (DRC): opportunities for improved maternal and child health. BMC Public Health (2008) 1.63
Condom use and correlates of African American adolescent females' infrequent communication with sex partners about preventing sexually transmitted diseases and pregnancy. Health Educ Behav (2002) 1.63
The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis (2008) 1.60
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58
Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol (2013) 1.58
Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections. J Clin Microbiol (2004) 1.57
Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56
"No one's at home and they won't pick up the phone": using the Internet and text messaging to enhance partner services in North Carolina. Sex Transm Dis (2014) 1.55
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ (2016) 1.54
Efficacy of an HIV prevention program among female adolescents experiencing gender-based violence. Am J Public Health (2006) 1.54
AIDS care and treatment in Sub-Saharan Africa: implementation ethics. Hastings Cent Rep (2006) 1.54
HIV discrimination and the health of women living with HIV. Women Health (2007) 1.52
Conducting unlinked anonymous HIV surveillance in developing countries: ethical, epidemiological, and public health concerns. PLoS Med (2009) 1.51
Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis (2010) 1.51
Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis (2002) 1.49
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis (2006) 1.48
Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis (2005) 1.46
Multicomponent Internet continuing medical education to promote chlamydia screening. Am J Prev Med (2005) 1.44
Migration, Multiple Sexual Partnerships, and Sexual Concurrency in the Garífuna Population of Honduras. AIDS Behav (2015) 1.44
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007. Antivir Ther (2009) 1.42
Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: a case for intensifying clinic-based prevention efforts. Sex Transm Dis (2002) 1.41
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis (2007) 1.37
Self-concept and adolescents' refusal of unprotected sex: a test of mediating mechanisms among African American girls. Prev Sci (2004) 1.37
Psychosocial and behavioral correlates of refusing unwanted sex among African-American adolescent females. J Adolesc Health (2002) 1.36
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine (2002) 1.36
High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis (2003) 1.35
Free distribution of insecticide treated bed nets to pregnant women in Kinshasa: an effective way to achieve 80% use by women and their newborns. Trop Med Int Health (2008) 1.33
Clinical evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx amplified DNA assay on the BD Viper™ system with XTR™ technology. Sex Transm Dis (2011) 1.33
Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol (2010) 1.33
Gang involvement and the health of African American female adolescents. Pediatrics (2002) 1.33
The pathogenesis of syphilis: the Great Mimicker, revisited. J Pathol (2006) 1.33
Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis (2008) 1.31
Molecular subtyping of Treponema pallidum from North and South Carolina. J Clin Microbiol (2005) 1.30
Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol (2007) 1.30
Patterns of disclosure of HIV status to infected children in a Sub-Saharan African setting. J Dev Behav Pediatr (2011) 1.29
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Public tolerance, private pain: stigma and sexually transmitted infections in the American Deep South. Cult Health Sex (2005) 1.29
HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis. BMC Public Health (2010) 1.28
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis (2011) 1.28